ArticleDrug delivery and translational research2021

Preclinical evaluation of a hypotonic docetaxel nanosuspension formulation for intravesical treatment of non-muscle-invasive bladder cancer.

Abhijit A Date et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.